Inventor
LOTAN TAMAR
IL19 patents
⚠️ This page may combine multiple inventors who share the name “LOTAN TAMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NANOCYTE INC
5 patentsUS6613344B2Sep 2, 2003
Methods utilizing stinging cells/capsules
NANOCYTE INC31 citations95
US7998509B2Aug 16, 2011
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
NANOCYTE INC5 citations73
US7632522B2Dec 15, 2009
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
NANOCYTE INC4 citations73
US7338665B2Mar 4, 2008
Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
NANOCYTE INC8 citations73
US7611723B2Nov 3, 2009
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
NANOCYTE INC6 citations71
LOTAN TAMAR
5 patentsUS8062660B2Nov 22, 2011
Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
LOTAN TAMAR7 citations83
US8287912B2Oct 16, 2012
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
LOTAN TAMAR4 citations62
US8337868B2Dec 25, 2012
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
LOTAN TAMAR2 citations60
US8486441B2Jul 16, 2013
Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
LOTAN TAMAR0 citations51
US8834862B2Sep 16, 2014
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
LOTAN TAMAR0 citations41
UNIV CALIFORNIA
4 patentsUS6235975B1May 22, 2001
Leafy cotyledon1 genes and methods of modulating embryo development in transgenic plants
UNIV CALIFORNIA57 citations94
US6320102B1Nov 20, 2001
Leafy cotyledon1 genes and their uses
UNIV CALIFORNIA31 citations91
US6781035B1Aug 24, 2004
Leafy cotyledon1 genes and their uses
UNIV CALIFORNIA36 citations90
US6545201B1Apr 8, 2003
Leafy cotyledon1 genes and their uses
UNIV CALIFORNIA16 citations82
YISSUM RES DEV CO
3 patentsUS5965795AOct 12, 1999
Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a beta-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants
YISSUM RES DEV CO36 citations95
US6218599B1Apr 17, 2001
Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants
YISSUM RES DEV CO18 citations92
US6903245B2Jun 7, 2005
Polynucleotide molecule from haematococcus pluvialis encoding a polypeptide having a ⊕-c-4-oxygenase activity for biotechnological production of (3s,3's) astaxanthin and its specific expression in chromoplasts of higher plants
YISSUM RES DEV CO0 citations51
(unassigned)
2 patentsUS6923976B2Aug 2, 2005
Methods compositions and devices utilizing stinging cells/capsules for delivering therapeutic or a cosmetic agent into a tissue
20 citations92
US5916791AJun 29, 1999
Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β--C--4--oxygenase activity for biotechnological production of (3S,3S)astaxanthin
24 citations91